Effects of d-amphetamine in grouped versus isolated human

Pharmacology Biochemistry and Behavior

Volumn 57, Issue 1-2, 1997, Pages 333-340

  De Wit, H ^a   Clark, M ^a   Brauer, L H ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aggregated; Amphetamine; Human; Isolated; Subjective effects; Temperature

Indexed keywords

CENTRAL STIMULANT AGENT; DEXAMPHETAMINE;

ADULT; ARTICLE; BEHAVIOR; BODY TEMPERATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GROUP DYNAMICS; HEART RATE; HUMAN; HUMAN EXPERIMENT; HYPERTHERMIA; MALE; MOOD; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANALYSIS OF VARIANCE; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; SEX DISTRIBUTION; SOCIAL ENVIRONMENT; SOCIAL ISOLATION;

ANIMALIA;

EID: 0031002832     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00316-4     Document Type: Article

References (39)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC. 1987.
2. Brauer, L.; de Wit, H. Role of dopamine in d-amphetamine-induced euphoria in normal, healthy volunteers. Experimental and Clinical Psychopharmacology 3:371-381; 1995.
3. Brauer, L.; de Wit, H. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol. Psychiatry 39:26-32; 1996.
4. Chance, M. R. Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice. J. Pharmacol. Exp. Ther. 87: 214-219; 1946.
5. Chieu, C. C.; Moore, K. E. d-amphetamine-induced release of "newly synthesized" and "stored" dopamine from the caudate nucleus in vivo. J. Pharmacol. Exp. Ther. 192:642-653; 1975.
6. Connors, G. J.; Tarbox, A. R. Macroenvironmental factors as determinants of substance use and abuse. In: Galizio, M.; Maisto, S. A., eds. Determinants of substance abuse: Biological, psychological, and environmental factors. New York: Plenum Press; 1985:283-314.
7. Craig, A. L.; Kupferberg, H. J. Hyperthermia and d-amphetamine toxicity in aggregated mice of different strains. J. Pharmacol. Exp. Ther. 180:616-624; 1972.
8. Doty, P.; de Wit, H. Effects of setting on the reinforcing and subjective effects of ethanol in social drinkers. Psychopharmacology 118:19-27; 1995.
9. de Wit, H.; Griffiths, R. R. Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend. 28:83-111; 1991.
10. Foltin, R. W.; Fischman, M. W. Assessment of abuse liability of stimulant drugs in humans: a methodological survey. Drug Alcohol Depend. 28:3-48; 1991.
11. Green, A. R.; Cross, A. J.; Goodwin, G. M. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy). Psychopharmacology 119:247-260; 1995.
12. Griffiths, R. R.; Stitzer, M.; Corker, K.; Bigelow, G. E.; Liebson, I. Drug produced changes in human social behavior: facilitation by d-amphetamine. Pharmacol. Biochem. Behav. 7:342-365; 1977.
13. Gunn, J. A.; Gurd, M. R. The action of some amines related to adrenaline. Cyclohexylalkylamines. J. Physiol. 97:453-470; 1940.
14. Henry, J. A.; Jeffreys, K. J.; Dawling, S. Toxicity and death from 3,4methylenedioxymethamphetamine ("ecstasy"). Lancet 340:384-387; 1992.
15. Higgins, S. T.; Stitzer, M. L. Effects of alcohol on speaking in isolated humans. Psychopharmacology 95:189-194; 1988a.
16. Higgins, S. T.; Stitzer, M. L. Time allocation in a concurrent schedule of social interaction and monetary reinforcement: effects of d-amphetamine. Pharmacol. Biochem. Behav. 31:227-231; 1988b.
17. Higgins, S. T.; Hughes, J. R.; Bickel, W. K. Effects of d-amphetamine on choice of social versus monetary reinforcement: a discrete trial test. Pharmacol. Biochem. Behav. 34:297-301; 1989.
18. Hindmarch, I.; Kerr, J. S.; Sherwood, J. The effects of alcohol and other drugs on psychomotor performance and cognitive function. Alcohol & Alcoholism 26:71-79; 1991.
19. Johanson, C. E.; Uhlenhuth, E. H. Drug preference and mood in humans: diazepam. Psychopharmacology 71:269-273; 1980.
20. Johanson, C. E.; de Wit, H. Lack of effect of social context on the reinforcing effects of diazepam in humans. Pharmacol. Biochem. Behav. 43:463-469; 1992.
21. Jones, R. T. Marihuana-induced "high": Influence of expectation, setting and previous drug experience. Pharmacological Reviews 23:359-369; 1971.
22. Keppel, G. Design and Analysis: A Researcher's Handbook. Englewood Cliffs, NJ: Prentice-Hall; 1982.
23. Kostarczyk, E.; Fonberg, E. Amphetamine effects on unconditional and conditional instrumental responses with alimentary and social rewards in dogs. Pav. J. Biol. Sci. 21:10-14; 1988.
24. Landauer, M. R.; Balster, R. L. The effect of aggregation on the lethality of phencyclidine in mice. Toxicology Letters 12:171-176; 1982.
25. Lokiec, F.; Jacquot, C.; Rapin, J. R.; Cohen, Y. Effects of amphetamine on brain biogenic amines in isolated and aggregated rats. Eur. J. Pharmacol. 44:391-395; 1977.
26. Lokiec, F.; Rapin, J. R.; Jacquot, C.; Cohen, Y. A comparison of the kinetics of d- and l-amphetamine in the brain of isolated and aggregated rats. Psychopharmacology 58:73-77; 1978.
27. Lokiec, F.; Jacquot, C.; Cohen, Y. Cageing density and dopamine striatal elimination after amphetamine in the rat. Psychopharmacology 73:402-403; 1981.
28. Martin, W. R.; Sloan, J. D.; Sapira, J. D.; Jasinski, D. R. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin. Pharmacol. Ther. 12:245-258; 1971.
29. McCarty, D. Environmental factors in substance abuse: the microsetting. In: Galizio, M.; Maisto, S. A., eds. Determinants of substance abuse: Biological, psychological, and environmental factors. New York: Plenum Press; 1985. 247-282.
30. McNair, D.; Lorr, M.; Droppleman, L. Profile of mood states. San Diego: Educational and Industrial Testing Service; 1971.
31. Mohrland, J. S.; Craigmill, A. L. The effect of aggregation on the lethality of morphine in mice. Arch. Int. Pharmacodyn. Ther. 236:252-265; 1978.
32. Moore, K. E.; Sawdy, L. C.; Shaul, S. R. Effects of d-amphetamine on blood glucose and tissue glycogen levels of isolated and aggregated mice. Biochem. Pharmacol. 14:197-204; 1965.
33. Nuotto, E. J.; Kortilla, K. T. Evaluation of a new computerized psychomotor test battery: Effects of alcohol. Pharmacol. Toxicol. 68:360-365; 1991.
34. Pliner, P.; Cappell, H. Modification of affective consequences of alcohol: a comparison of social and solitary drinking. J. Abnorm. Psychol. 83:418-425; 1974.
35. Stitzer, M.; Griffiths, R. R.; Bigelow, G. E.; Liebson, I. Human social conversation: effects of ethanol, secobarbital and chlorpromazine. Pharmacol. Biochem. Behav. 14:353-360; 1981.
36. Vargas-Rivera, J.; Ortega-Corona, B. G.; Garcia Pineda, J.; Carranza, J.; Salazar, L. A.; Villarreal, J. Influence of previous housing history on the toxicity of amphetamine in aggregate mice. Archives de Investigacion Medica 21:65-69; 1990.
37. Wechsler, D. The measurement and appraisal of adult intelligence. Baltimore, MD: Williams & Wilkins; 1958.
38. Wolf, H.H.; Bunce, M. E. Hyperthermia and the amphetamine aggregation phenomenon: absence of a causal relation. J. Pharm. Pharmacol. 25:425-427; 1973.
39. Zacny, J. P.; Bodker, B. K.; de Wit, H. Effects of setting on the subjective and behavioral effects of d-amphetamine in humans. Addictive Behaviors: 17:27-33. 1992.